• Moxifloxacin in Cell Viability Assays

  2026-08-20

  This scenario-driven guide explains how Moxifloxacin (SKU B1218) can support reproducible studies of cell viability, proliferation, antibiotic toxicity, and metabolic response. It connects product handling data with concentration-dependent retinal ganglion cell findings while defining appropriate controls, interpretation limits, and vendor-selection criteria.

• cgSHAPE-seq Maps SARS-CoV-2 RNA Binding Sites

  2026-08-20

  This reference preprint introduces cgSHAPE-seq, a chemical-guided sequencing method that identifies RNA-ligand binding sites at single-nucleotide resolution. Applied to the SARS-CoV-2 5′ untranslated region, the approach localized coumarin C30 to a bulged guanosine in the SL5 structure and guided development of RNase L-recruiting RNA degraders, including C64, which inhibited live-virus replication in cells.

• 10 mM dNTP Mixture for PCR and LNP Assays

  2026-08-19

  Learn how an equimolar 10 mM dNTP mixture supports reproducible PCR, qPCR, sequencing preparation, and DNA-based lipid nanoparticle trafficking assays. The workflow connects precise nucleotide control with the reference study’s finding that excess cholesterol can trap LNP cargo in peripheral early endosomes.

• Shenqi Fuzheng Blocks Glioma via SRC/PI3K/AKT

  2026-08-19

  This study combines network pharmacology with cell-based and mouse experiments to define how Shenqi Fuzheng injection suppresses glioma proliferation and migration. Its evidence prioritizes the SRC/PI3K/AKT axis and provides a practical framework for connecting multi-component herbal formulations with experimentally testable glioma phenotypes.

• Quaternization Reprograms Lung-Targeted mRNA Delivery

  2026-08-18

  The reference study shows that N-quaternization of a lipid-like carrier can convert systemic mRNA distribution from spleen preference to highly selective lung delivery without adding a targeting ligand. Its findings provide a useful design framework for comparing carrier chemistry, organ tropism, pulmonary immune-cell uptake, and productive mRNA translation.

• Dibutyryl-cAMP, sodium salt: Applied Workflows

  2026-08-18

  Dibutyryl-cAMP, sodium salt provides a practical way to elevate intracellular cAMP and interrogate PKA-linked biology in cells, inflammatory models, and neuronal systems. This guide converts pathway biology into controlled dosing, assay design, troubleshooting, and tissue-relevant experiments while separating established findings from exploratory applications.

• Vardenafil in Proteoform-Resolved PDE5 Research

  2026-08-17

  Vardenafil HCl Trihydrate offers a powerful reference point for connecting PDE5 inhibition, cGMP signaling, smooth muscle relaxation research, and native-membrane proteoform analysis. This article moves beyond conventional potency claims to outline a translational workflow that evaluates isoform selectivity, functional responses, off-target PDE6 interactions, and compound handling in a context-aware manner.

• Tofacitinib Citrate: JAK3 Research Workflows

  2026-08-17

  Tofacitinib citrate supports concentration-aware studies of lymphocyte signaling, cytokine responses, and endothelial inflammation. This guide separates immune pathway inhibition from vascular protection so researchers can select readouts, controls, and doses that answer distinct mechanistic questions.

• Nocodazole and the Logic of Microtubule Perturbation

  2026-08-16

  A translational framework for using Nocodazole as a microtubule polymerization inhibitor to connect microtubule dynamics research, cell cycle regulation assays, pathogen entry studies, and anticancer drug evaluation.

• CTOP for Mechanistic Opioid Pain Research

  2026-08-15

  CTOP is a selective μ-opioid receptor antagonist for separating MOR-dependent signaling from downstream spinal and behavioral effects. This guide translates recent circuit-level findings into practical assay and control strategies for opioid receptor binding studies and pain mechanism research.

• β-Elemene: AMPK Adipogenesis Workflow Guide

  2026-08-14

  Use β-Elemene as a mechanistic probe in adipocyte differentiation, insulin-resistance, lipid-accumulation, and AMPK studies. This guide translates a recent 3T3-L1 workflow into practical dosing, assay-selection, formulation, and troubleshooting decisions while distinguishing metabolic evidence from emerging anticancer and neuroprotective applications.

• Gly-Gly-Phe-Gly (GGFG) for Drug Conjugation

  2026-08-14

  Gly-Gly-Phe-Gly (GGFG) provides a compact, flexible peptide scaffold for controlled drug conjugation, antibody-drug conjugate development, and peptide engineering. This practical guide connects linker selection with assay design, workflow controls, and the ER-stress biology highlighted in a multiple myeloma combination-therapy study.

• Letrozole A1307: Reliable Assay Design

  2026-08-13

  A scenario-based guide to using Letrozole (SKU A1307) in cell viability, proliferation, and endocrine-response assays. It translates the compound’s 11.5 nM aromatase IC50, DMSO solubility, storage requirements, and reversible mechanism into practical experimental decisions.

• CTOP: A μ-Opioid Receptor Antagonist

  2026-08-13

  A translational framework for using CTOP to test μ-opioid receptor causality in opioid-induced mechanical hypersensitivity, tolerance, and brain-to-spinal pain circuits.

• Nicotinamide Riboside Chloride in RGC Models

  2026-08-12

  Nicotinamide Riboside Chloride (NIAGEN) adds a controllable NAD+ metabolism variable to reproducible iPSC-derived retinal ganglion cell workflows. This article shows how to separate lineage-generation effects from metabolic resilience, with practical dosing, controls, and troubleshooting for glaucoma and broader neurodegenerative disease models.

16427 records 1/1096 page Next 12345 下5页 Last page